Recent Comments

Comment RSS

Congestive Heart Failure News and Research RSS Feed - Congestive Heart Failure News and Research

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

Employers take action to improve medication adherence

21. November 2009 00:31
More employers are taking steps to improve their employees' health by making sure they take their medicines as prescribed, a move that could stave off more serious and costly health consequences, according to a new report sponsored by the National Pharmaceutical Council (NPC). [More]

Medical report showing the devastating impacts of coal on human body released

19. November 2009 03:32
Physicians for Social Responsibility today released a groundbreaking medical report, "Coal's Assault on Human Health," which takes a new look at the devastating impacts of coal on the human body. [More]

Publicly released report cards do not appear to improve hospitals' performance, says new study

19. November 2009 02:09
An analysis of quality of cardiac care following the public release of data on measures of care at hospitals in Ontario, Canada, did not result in significant systemwide improvement in hospitals' performance on most quality of care indicators, according to a study to be published in the December 2 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference. [More]

Posted in: Healthcare News

Tags: , , , ,

Homecare, an important part of the solution to nation's healthcare crisis

18. November 2009 06:55
During November -- National Homecare Month -- the American Association for Homecare celebrates the thousands of dedicated professionals who provide cost-effective and consumer-preferred homecare. [More]

Global market challenges in the sleep apnea diagnostic and therapeutic devices market

18. November 2009 06:51
Sleep Apnea Diagnostic and Therapeutic Devices - Worldwide Market Challenges & Opportunities [More]

Posted in: Device / Technology News

Tags: , , , ,

Health Net’s MA product portfolio offers budget-friendly health plan choices to beneficiaries for 2010

17. November 2009 05:07
With the kick-off of the Medicare Annual Election Period (AEP) this week, Health Net, Inc. reminds those eligible for Medicare that Health Net’s Medicare Advantage (MA) product portfolio offers a comprehensive range of budget-friendly health plan choices to beneficiaries for 2010. [More]

Genentech submits sBLAs to the FDA for Avastin

17. November 2009 03:36
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy. [More]

Stem cell therapy to treat heart, lung and vascular diseases show positive results

16. November 2009 23:32
A Florida cardiologist is using stem cell therapy to treat patients who suffer from a range of heart, lung and vascular illnesses. The results have been extraordinary. [More]

Study of GBHN Order Set project reveals improvements in the length of stay and ordering of best practices

13. November 2009 08:44
A study of the Grey Bruce Health Network (GBHN) Order Set project has revealed impressive improvements in the length of stay and ordering of best practices. [More]

Third-quarter 2009 results announced by Response Biomedical

10. November 2009 07:46
Response Biomedical Corporation today announced financial results for the third quarter and nine months ended September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , , , , ,

Average cost of patient deaths much higher than patients who were discharged alive

6. November 2009 00:18
One of every three people who died in 2007 in the United States were in the hospital for treatment at the time of their deaths, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The cost of their hospital stays was about $20 billion. [More]

Posted in: Healthcare News

Tags: , , , , , , , ,

Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR

3. November 2009 06:58
Acorda Therapeutics, Inc. today announced its financial results for the third quarter of 2009. [More]

Amgen publishes Phase 3 study results of Aranesp

31. October 2009 05:14
Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes. [More]

Nonin Medical receives Medical Technology Award for Onyx II, Model 9560

30. October 2009 04:10
Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, was awarded the Medical Technology Award and its owner and CTO, Phil Isaacson received the Technology Executive of the Year by the Minnesota High Tech Association (MHTA), in partnership with Enterprise Minnesota and LifeScience Alley. [More]

Cardiome Pharmam, Astellas Pharma begin patient enrolment for ACT 5 trial

29. October 2009 04:17
Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that patient enrolment has begun for the ACT 5 trial, a confirmatory Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection, a drug product candidate under development for the rapid conversion of atrial fibrillation to sinus rhythm. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.